PR Masters Series

PR Masters Series


PR Masters Series Podcast, Episode #18 – Gil Bashe

November 18, 2019

Overview
The Stevens Group is pleased to present a new podcast series that salutes the masters of public relations and revels in their observations, insights and advice to PR professionals.  This new series is part of the ongoing partnership between The Stevens Group and CommPRO to bring to PR, digital/interactive and marketing communications agencies the wisdom of those who have reached the top of the PR profession.

 

 
About Our Guest
Gil Bashe, Managing Partner, Finn Partners Global Health Practice

Champion for health innovation to sustain life and improve patient care, Gil has been tapped by PharmaVOICE "as one of the 100 most inspiring people in healthcare;" included in the Fast Company “50 People to Watch in the New World of Work”; chosen as a MM&M Top 10 Innovation Catalyst; by PRWeek/MM&M as a Top 50 Health Influencer;" recognized by the PRSA Health Academy with its "Excellence in Public Relations" award, and selected for the PRNews "Hall of Fame." American Heart Association and Marfan Foundation advocate for patient engagement and access to care. Gil has led three top agencies cited by The Holmes Report as "Healthcare PR Agency of the Year" winners.

Gil is associated with 40+ product launch campaigns for global med/tech and biopharma blockbusters in cancer, diabetes, heart, respiratory, women's health and non-communicable and orphan disease therapies. His background in payer, provider, policy, pharma marketing and patient-advocacy communications enables him to integrate ideas that impact patient access to care. He enables client messages and ideas to navigate successfully through the complex health ecosystem.

Dedicated to inspiring colleagues to succeed for clients and their customers, he was Group Company CEO, CommonHealth, and at WPP Group sister-company Hill + Knowlton, EVP, Worldwide Health Practice Director - its first Global Practice Head. He served as CEO of Health!Quest Global Communication Partners, funded by GTCR Golder Rauner, a private-equity firm, now with $10 billion in active assets.

Gil held leadership positions with New York agency Makovsky, Medicus, a global health-marketing company (today part of Publicis Healthcare), and at the pioneering integrated health-marketing agency Sutton Healthcare Group. As a health lobbyist, he was a director with the New Jersey Health Products Council.  He serves on the advisory boards of Lets Win for Pancreatic Cancer, Marfan Foundation and Galien Foundation.  He is also a member of the CNS Summit organizing committee and was honored by the Summit for his leadership role in the life science community. He completed his military service as a paratrooper combat medic and staff sergeant.